EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C12H16N2O2 |
| Net Charge | 0 |
| Average Mass | 220.272 |
| Monoisotopic Mass | 220.12118 |
| SMILES | c1cc2c(c(N3CCNCC3)c1)OCCO2 |
| InChI | InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2 |
| InChIKey | WVLHGCRWEHCIOT-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. |
| Applications: | antidyskinesia agent Any compound which can be used to treat or alleviate the symptoms of dyskinesia. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| eltoprazine (CHEBI:234413) has role antidyskinesia agent (CHEBI:66956) |
| eltoprazine (CHEBI:234413) has role anxiolytic drug (CHEBI:35474) |
| eltoprazine (CHEBI:234413) has role serotonergic agonist (CHEBI:35941) |
| eltoprazine (CHEBI:234413) is a benzodioxine (CHEBI:64096) |
| eltoprazine (CHEBI:234413) is a piperazines (CHEBI:26144) |
| eltoprazine (CHEBI:234413) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine |
| INNs | Source |
|---|---|
| eltoprazine | WHO MedNet |
| eltoprazine | WHO MedNet |
| eltoprazina | WHO MedNet |
| eltoprazinum | WHO MedNet |
| Synonyms | Source |
|---|---|
| N-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine | ChEBI |
| 1-(2,3-dihydro-1,4-benzodioxan-5-yl)piperazine | ChEBI |
| 4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine | ChEBI |
| 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazine | ChEBI |
| 1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB12883 | DrugBank |
| HMDB0251757 | HMDB |
| Eltoprazine | Wikipedia |
| WO2011000565 | Patent |
| WO2011000563 | Patent |
| WO2011000564 | Patent |
| WO2009156380 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:98224-03-4 | DrugBank |
| Citations |
|---|